Aveanna Healthcare (NASDAQ:AVAH) Major Shareholder Sells $7,355,112.00 in Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder J.H. Whitney Equity Partners V sold 919,389 shares of Aveanna Healthcare stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $8.00, for a total value of $7,355,112.00. Following the transaction, the insider owned 12,531,158 shares in the company, valued at $100,249,264. This represents a 6.84% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Large shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

J.H. Whitney Equity Partners V also recently made the following trade(s):

• On Wednesday, June 3rd, J.H. Whitney Equity Partners V sold 5,842,240 shares of Aveanna Healthcare stock. The stock was sold at an average price of $6.24, for a total transaction of $36,455,577.60.

Aveanna Healthcare Stock Performance

AVAH stock opened at $8.64 on Monday. The firm has a 50 day simple moving average of $7.14 and a 200 day simple moving average of $7.57. Aveanna Healthcare Holdings Inc. has a 52 week low of $3.73 and a 52 week high of $10.32. The stock has a market cap of $1.88 billion, a P/E ratio of 7.32, a P/E/G ratio of 0.89 and a beta of 1.93. The company has a debt-to-equity ratio of 5.35, a quick ratio of 1.47 and a current ratio of 1.47.

Aveanna Healthcare (NASDAQ:AVAH) last released its quarterly earnings data on Thursday, May 14th. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.13 by $0.05. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%. The firm had revenue of $647.91 million for the quarter, compared to analyst estimates of $613.22 million. The company’s quarterly revenue was up 15.9% on a year-over-year basis. Research analysts anticipate that Aveanna Healthcare Holdings Inc. will post 0.65 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several analysts recently issued reports on the company. Royal Bank Of Canada upgraded Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 price objective for the company in a report on Wednesday, June 3rd. Truist Financial lifted their price target on Aveanna Healthcare from $8.00 to $9.00 and gave the company a “hold” rating in a report on Wednesday, May 20th. Weiss Ratings cut Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, April 6th. Stephens upgraded Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and increased their price objective for the stock from $10.00 to $11.00 in a report on Friday, May 15th. Finally, BMO Capital Markets cut their price objective on shares of Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating on the stock in a research report on Friday, March 20th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, Aveanna Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $10.50.

Institutional Investors Weigh In On Aveanna Healthcare

A number of large investors have recently bought and sold shares of the business. Caitong International Asset Management Co. Ltd increased its position in Aveanna Healthcare by 252.4% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after buying an additional 2,400 shares during the last quarter. Quantbot Technologies LP bought a new position in Aveanna Healthcare during the second quarter valued at about $43,000. Summit Securities Group LLC acquired a new stake in shares of Aveanna Healthcare in the first quarter worth about $53,000. Oxford Asset Management LLP acquired a new stake in shares of Aveanna Healthcare in the second quarter worth about $64,000. Finally, Bayesian Capital Management LP bought a new stake in shares of Aveanna Healthcare during the 2nd quarter worth about $85,000. 87.96% of the stock is currently owned by institutional investors.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.